Details for Patent: 8,440,722
✉ Email this page to a colleague
Which drugs does patent 8,440,722 protect, and when does it expire?
Patent 8,440,722 protects COLCRYS and is included in one NDA.
Summary for Patent: 8,440,722
Title: | Methods for concomitant administration of colchicine and a second active agent |
Abstract: | Methods for concomitant administration of colchicine together with one or more second active agents, e.g., verapamil, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided. |
Inventor(s): | Davis; Matthew W. (Erwinna, PA) |
Assignee: | Takeda Pharamceuticals U.S.A., Inc. (Deerfield, IL) |
Application Number: | 13/454,255 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,440,722 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,440,722
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | COLCRYS | colchicine | TABLET;ORAL | 022352-001 | Jul 29, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF USING COLCHICINE FOR THE PROPHYLAXIS OF GOUT FLARES | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |